UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Self-reported psychedelic retreat survey findings on participant benefits for depression & anxiety
This report is from a non-medical psychedelic retreat centre documenting participant responses to a series of surveys on continuing benefits for depression and anxiety symptoms.
Incannex announces positive topline results from phase 2 Psi-GAD1 clinical trial of psilocybin in generalised anxiety disorder
This is the first time psilocybin has been investigated for treatment of generalised anxiety disorder, and the reduction in HAM-A scores we have observed are far greater those reported from trials on established medicines for treatment of anxiety.
MindMed announces positive 12-week data from phase 2B study of MM120 for GAD
FDA has granted breakthrough designation to its MM120 (lysergide d-tartrate) program for the treatment of generalized anxiety disorder (GAD)."
Exposure therapy under psilocybin for general anxiety disorder and claustrophobia
The protocol included both an imaginary exposure exercise and a classic exposure therapy in an elevator during the psilocybin-assisted psychotherapy.
Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness A randomized, double-blind, placebo-controlled Phase II study
LSD produced long-lasting and notable reductions of anxiety and comorbid depression symptoms up to 16 weeks.
Decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees
Results suggest rapid and persisting (up to 1 week) anxiolytic effects in individuals with sub-clinical anxiety symptoms
Effects of naturalistic psychedelic use on depression, anxiety, and well-being: Associations with patterns of use, reported harms, and transformative mental states
the current study add to a growing database indicating that psychedelic use may provide a wide range of mental health benefits
Research study suggests psychedelics promote positive mental health through increased spirituality and emotion regulation
A new study published in the Journal of Humanistic Psychology proposes the mechanism connecting psychedelic use to improved mental health
Psilocybin microdosing does not reduce anxiety or depression according to placebo-controlled study
Consuming small doses of psilocybin at regular intervals — a process known as microdosing — does not appear to improve symptoms of depression or anxiety